164 related articles for article (PubMed ID: 26126642)
1. Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.
Tomizawa D; Watanabe T; Hanada R; Horibe K; Horikoshi Y; Iwamoto S; Kinoshita A; Moritake H; Nakayama H; Shimada A; Taga T; Takahashi H; Tawa A; Terui K; Hori H; Kawano Y; Kikuta A; Manabe A; Adachi S
Int J Hematol; 2015 Sep; 102(3):318-26. PubMed ID: 26126642
[TBL] [Abstract][Full Text] [Related]
2. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
5. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study.
White VM; Skaczkowski G; Pinkerton R; Coory M; Osborn M; Bibby H; Nicholls W; Orme LM; Conyers R; Phillips MB; Harrup R; Walker R; Thompson K; Anazodo A
Pediatr Blood Cancer; 2018 Nov; 65(11):e27349. PubMed ID: 30039912
[TBL] [Abstract][Full Text] [Related]
7. Family History and Relapse in Pediatric Acute Myeloid Leukemia.
Mehrvar A; Tashvighi M; Faranoush M; Reinhardt D; Niktoreh Mofrad N; Hedayati Asl AA; Alebouyeh M
Pediatr Blood Cancer; 2015 Dec; 62(12):2235-7. PubMed ID: 26184891
[TBL] [Abstract][Full Text] [Related]
8. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
9. Improved outcome of childhood acute myeloid leukemia in an Eastern European country: Lithuanian experience.
Kairiene I; Pasauliene R; Lipunova N; Vaitkeviciene G; Rageliene L; Rascon J
Eur J Pediatr; 2017 Oct; 176(10):1329-1337. PubMed ID: 28812191
[TBL] [Abstract][Full Text] [Related]
10. Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).
Pemmaraju N; Kantarjian H; Ravandi F; Nogueras-Gonzalez GM; Huang X; O'Brien S; Wierda W; Garcia-Manero G; Thomas D; Pierce S; Verstovsek S; Borthakur G; Cortes J
Clin Lymphoma Myeloma Leuk; 2016 Apr; 16(4):213-222.e2. PubMed ID: 26838606
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia in adolescents and young adults: challenging aspects.
Ofran Y; Rowe JM
Acta Haematol; 2014; 132(3-4):292-7. PubMed ID: 25228554
[TBL] [Abstract][Full Text] [Related]
12. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
Creutzig U; Reinhardt D; Diekamp S; Dworzak M; Stary J; Zimmermann M
Leukemia; 2005 Aug; 19(8):1355-60. PubMed ID: 15920490
[TBL] [Abstract][Full Text] [Related]
13. Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study.
Taga T; Shimomura Y; Horikoshi Y; Ogawa A; Itoh M; Okada M; Ueyama J; Higa T; Watanabe A; Kanegane H; Iwai A; Saiwakawa Y; Kogawa K; Yamanaka J; Tsurusawa M
Pediatr Blood Cancer; 2011 Jul; 57(1):36-40. PubMed ID: 21557456
[TBL] [Abstract][Full Text] [Related]
14. Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004.
Løhmann DJ; Abrahamsson J; Ha SY; Jónsson ÓG; Koskenvuo M; Lausen B; Palle J; Zeller B; Hasle H
Haematologica; 2016 Nov; 101(11):1359-1367. PubMed ID: 27470605
[TBL] [Abstract][Full Text] [Related]
15. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
[TBL] [Abstract][Full Text] [Related]
16. Improved treatment results for childhood acute myeloid leukemia in Taiwan.
Liang DC; Chan TT; Lin KH; Lin DT; Lu MY; Chen SH; Liu HC; Lin MT; Lee MT; Shu SG; Chang TK; Chen JS; Hsiao CC; Hung IJ; Hsieh YL; Chen RL; Cheng SN; Chang WH; Lee CH; Lin KS
Leukemia; 2006 Jan; 20(1):136-41. PubMed ID: 16281075
[TBL] [Abstract][Full Text] [Related]
17. Mortality in overweight and underweight children with acute myeloid leukemia.
Lange BJ; Gerbing RB; Feusner J; Skolnik J; Sacks N; Smith FO; Alonzo TA
JAMA; 2005 Jan; 293(2):203-11. PubMed ID: 15644547
[TBL] [Abstract][Full Text] [Related]
18. Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.
Woods WG; Franklin AR; Alonzo TA; Gerbing RB; Donohue KA; Othus M; Horan J; Appelbaum FR; Estey EH; Bloomfield CD; Larson RA
Cancer; 2013 Dec; 119(23):4170-9. PubMed ID: 24104597
[TBL] [Abstract][Full Text] [Related]
19. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
Skou AS; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750
[TBL] [Abstract][Full Text] [Related]
20. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]